Skip to content

APOTHEEK MANN

Active Private limited company (pre-2019)founded 2009active for 17 yearsJan Van Rijswijcklaan 82, 2018 AntwerpKBO/BCE: BE 0815.855.617 subsidiary of

Lifetime

16 annual accounts with figures on one time axis
peak of €392,421 in 2025
€392,421▲ 34.8%
lowest -€8,302 in 2012
€147,671▲ 87.8%
peak of €358,394 in 2025
€358,394▲ 8.4%
€734,640▼ 11.7%
peak of 2.5 FTE in 2014
2.2 FTE▲ 22.2%
Board2 names since 2019
1 director
Owners
100%
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Gross margin from €291,021 to €392,421Result from €78,626 to €147,671Staff from 1.8 FTE to 2.2 FTECash from €6,348 to €19,637

Key points

from the 2025 annual accounts

Equity

€358,394 ▲ 8.4%

APOTHEEK MANN has made a profit without a break since 2013.

Result

€147,671 ▲ 87.8%
€78,6002024€148,0002025

The result rose in 2025 from €78,626 to €147,671.

Turnover

≈ €1.4m estimated

The abbreviated format states no turnover.

Staff

3 employees on 31-12-2025
332021442022112023322025

In 2025, 3 employees joined and 2 left.

Filings

16 annual accounts since 2010
AprilJune31 JulyOctober2010201520202025

Seven of the last ten came late. The 2019 accounts came in latest, 129 days after the end of the period.

Position in the sector

€147,671

Higher net result than 80% of companies in retail trade. Sector median €38,025 · 13,262 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,726 companies had the same profile as APOTHEEK MANN has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,726 companies, not a prediction for APOTHEEK MANN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, , since 01-01-2019
  • 100%equity €612,382 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0815855617
New manager appointed, resigned · acts as permanent representative · General meeting of 01-01-2019 · Gazette deed
Capital increase of €77,400 to €96,000 The capital rose from €18,600 to €96,000 · Gazette deed
First establishment Jan Van Rijswijcklaan 82, Antwerp
All 27 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK MANN Antwerp €1.1m €392,421 32.8% 2.2
PHARMACIE DU DIEWEG Uccle €1.2m €372,589 88.8% 2.3
Apotheek Verachtert-Gysen Pelt €1.0m €401,112 78.2% 2
KRUISPUNT APOTHEEK Antwerp €1.0m €417,397 41.4% 2.7
Sego Pharma Dessel €0.9m €397,420 63.7% 1.7
APOTHEEK JOOSEN Wommelgem €0.9m €322,076 88.0% 2.1
Apotheek WAEGHE - VAN GELUWE DE BERLAERE Nazareth-De Pinte €1.2m €388,601 27.7% 2.5

These companies have the same main activity as APOTHEEK MANN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €876,000 and €1.2m, founded between 2007 and 2010.

Official details

Source: KBO
Status
Active since 26-06-2009Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.179.708.3782018 Antwerp, since 01-07-2009
Financial year end
31 December
Peppol
Reachable since 17-06-2025
Company details

Annual accounts 2025

€1.1m▼ 6.0%
Employeeson 31-12-2025
3▲ 50.0%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on APOTHEEK MANN

APOTHEEK MANN files the abbreviated format. That format states no turnover. The gross margin rose from €368,164 in 2010 to €392,421 in 2025.

The balance sheet grew most from 2021 to 2023 through fixed assets, financed with long-term debt.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK MANN

What is the company number of APOTHEEK MANN?
The company number of APOTHEEK MANN is 0815.855.617. The VAT number is the same number with BE in front: BE 0815.855.617.
Where is APOTHEEK MANN based?
The registered office is at Jan Van Rijswijcklaan 82, 2018 Antwerp.Company details
What does APOTHEEK MANN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK MANN?
APOTHEEK MANN is a private limited company (pre-2019) (BVBA).
When was APOTHEEK MANN founded?
APOTHEEK MANN was founded on 26-06-2009.
Is APOTHEEK MANN still active?
Yes, APOTHEEK MANN is an active enterprise in the KBO register.
How many employees does APOTHEEK MANN have?
APOTHEEK MANN had an average of 2.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK MANN fall under?
In its 2025 annual accounts, APOTHEEK MANN states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK MANN?
The turnover in financial year 2025 is ≈ €1.4m. This figure is estimated from the gross margin of €392,421 and 42 comparable companies (NACE 477). It probably lies between €1.1m and €1.9m.
Is APOTHEEK MANN profitable?
In financial year 2025, APOTHEEK MANN made a profit of €147,671.
Where can I find the annual accounts of APOTHEEK MANN?
APOTHEEK MANN filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK MANN due?
APOTHEEK MANN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.